Peer-influenced content. Sources you trust. No registration required. This is HCN.
Journal of the American College of Cardiology (JACC)
The P-WCD demonstrated a clinically significant cutaneous adverse device effect rate of only 2.30%, with no severe adverse events reported, suggesting a favorable safety profile for this novel wearable defibrillator.
Cardiology August 5th 2024
The Medical Futurist
Non-invasive digital health tools, including wearable sensors and tremor-suppressing devices, are emerging as valuable adjuncts to traditional treatments for tremor management, significantly enhancing patient autonomy and quality of life.
Internal Medicine May 28th 2024
The New England Journal of Medicine
Wearable digital health technologies are setting a new standard in patient care, offering insights into daily physiological and behavioral patterns that were previously inaccessible, enabling a more nuanced approach to disease management and patient engagement.
All Specialties April 3rd 2024